Lipigon Pharmaceuticals

0.00 SEK

-7.69 %

Less than 1K followers

LPGO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

-7.69 %
-35.71 %
-66.67 %
-58.14 %
-96.45 %
-96.10 %
-99.08 %
-99.92 %
-99.94 %

Lipigon Pharmaceuticals operates in the pharmaceutical industry. The company specializes in research and development of various drug candidates. The product portfolio is broad and includes drugs for rare diseases. These are primarily treatments for diseases caused by disorders in the body's handling of fats. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in the Nordic market.

Read more
Market cap
2.18M SEK
Turnover
59.63K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
18.5
2026

General meeting '26

28.5
2026

Interim report Q1'26

25.8
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.